Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of ELONVA in Usual Practice.
Phase of Trial: Phase IV
Latest Information Update: 11 May 2017
At a glance
- Drugs Corifollitropin alfa (Primary)
- Indications Infertility
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 10 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2017.
- 12 Dec 2016 Status changed from recruiting to active, no longer recruiting.